Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA017380-01S1
Application #
6938156
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Lin, Geraline
Project Start
2004-04-16
Project End
2009-03-31
Budget Start
2004-08-01
Budget End
2005-03-31
Support Year
1
Fiscal Year
2004
Total Cost
$38,056
Indirect Cost
Name
University of Houston
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
036837920
City
Houston
State
TX
Country
United States
Zip Code
77204
Donica, Courtney L; Awwad, Hibah O; Thakker, Deepak R et al. (2013) Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Mol Pharmacol 83:907-18
Zhang, Yong; Donica, Courtney L; Standifer, Kelly M (2012) Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment. Neuropharmacology 63:427-33
Donica, Courtney L; Ramirez, Vanessa I; Awwad, Hibah O et al. (2011) Orphanin FQ/nociceptin activates nuclear factor kappa B. J Neuroimmune Pharmacol 6:617-25
Sherry, David M; Mitchell, Robert; Standifer, Kelly M et al. (2006) Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina. BMC Neurosci 7:54
Desai, Aarti N; Salim, Samina; Standifer, Kelly M et al. (2006) Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor. J Pharmacol Exp Ther 317:1027-35
Ozsoy, Hatice Z; Thakker, Deepak R; Standifer, Kelly M (2005) Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation. Mol Pharmacol 68:447-56
Desai, Aarti N; Standifer, Kelly M; Eikenburg, Douglas C (2005) Cellular G protein-coupled receptor kinase levels regulate sensitivity of the {alpha}2b-adrenergic receptor to undergo agonist-induced down-regulation. J Pharmacol Exp Ther 312:767-73